I think it adds up pretty well. Not meaning to be argumentative, but just sharing a little more info to substantiate my differing opinion on the matter.
The new hires in management seem to be skewed substantially toward folks with M&A experience. Too many to be random; they must be seeking this background. If they weren't planning to be acquired, they would be focused more on other lines of experience.
Meanwhile, they have been hiring development folks to build a team; they have transitioned from a mostly external/contract development model to a mostly in-house development model, and this team is a big part of the value equation for Medtronic. Anyone feel like researching Mazor's Advanced Technology group? Medtronic acquired the whole company, including that development team. Medtronic obviously likes that type of talent pool, and that is what Titan now has to offer to an acquirer. This Titan team knows Enos inside and out now, and they also co-developed some new tech with and for Medtronic - wish I knew what the tech is, but I guess that defeats the purpose of a secret project...
The point is that the new management hires point to an increased likelihood of buyout due to the M&A experience. The engineering hires point to a more likely buyout because Medtronic showed us with the Mazor acquisition that they like bringing on an experienced team with something to show for their efforts. And the re-shuffling of the BOD also brings more M&A background to the table.
My math says this adds up very nicely in favor of a buyout. And I'm kind of a math guy. I just wish I knew when! But I cannot deny that they have been preparing for it.
Message in reply to:
Looking less and less likely there will be a buyout by Medtronic.
Too many hires
Another reshuffling of the BOD
Doesn’t add up
